Orsini, a leader in rare disease pharmacy solutions, has been selected by Genetix Biotherapeutics Inc. as a specialty ...
Total revenue of $68.7 million in 4Q25 and $172.4 million in FY2025 – – Revuforj® (revumenib) net revenue of $44.2 million in 4Q25, a 38% increase vs 3Q25, and $124.8 million in FY2025 – – Niktimvo™ ...
Conventional PCR systems require users to set a predetermined number of cycles based on assay- and sample-specific factors. When performing single-cell sequencing experiments, this requires knowledge ...
Sickle cell disease (SCD) makes red blood cells rigid and sickle-shaped, which can block blood flow. This can cause pain crises, infections, and other serious complications. Medications are often the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results